Abbott Laboratories Corporation

Other

Christopher T Cordle

Chron-Si Lai

John B Lasekan

Joseph P Schaller

Geralyn O Duska-McEwen

Keith A Garleb

Steven R Davis

Ronald L Thomas

Patricia A Reynolds

Marlene W Borschel

Russell J Merritt

Paul W Johns

Gary E Katz

Sean Garvey

Phyllis J Acosta

Steven T Luebbers

Lynn P Nelles

Eric Torgerson

Roger Tyre

Larry Grant Criswell

Phyllis J B Acosta

Shih-Bin Lin

Larry W Williams

Geralyn Duska-Mcewen

Powdered nutritional products containing branched-chain amino acids and a sugar alcohol are provided. The branched-chain amino acids in the powdered nutritional product exhibit improved solubility and thus improved dissolution upon reconstitution of the powdered nutritional product.

Powdered nutritional product containing branched-chain amino acids and a sugar alcohol

Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.

Nutritional products including a novel fat system including fatty acids

Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child

Nutritional products including monoglycerides and fatty acids

This invention relates to a palatable elemental nutritional formula that is nutritionally complete for humans with specialized dietary needs. The nutritional of the present invention uses specific free amino acids to provide the source of amino nitrogen (protein equivalents) and a special blend of fats that provides 38 to 50% of the total Calories in a pleasant tasting formula. The nutritionally complete formula of this invention is useful for children having multiple protein allergies, short gut syndrome, sick gut, diarrhea and the like. More specifically, the nutritional product, in accordance with this invention, utilizes L-asparagine monohydrochloride and L-glutamine in place of L-aspartic acid and L-glutamic acid, respectively. In addition, the source of fat comprises soy, fractionated coconut oil (medium chain triglycerides), high oleic safflower oil and esterified glycerol emulsifiers. The level of fat Calories is about 38 to 50% of total Calories, which produces a product having a low osmolarity and provides required energy requirements in a small volume.

Palatable elemental medical food

A method for debittering and reducing the allergenic reactivity of protein hydrolysates is disclosed, which method includes the providing of an aqueous solution of a protein hydrolysate, feeding the solution into a bed of siloxane, and collecting a first portion of the solution exiting from the bed. The first portion contains either a non-bitter or bitter fraction. A second portion of the solution exiting from the bed can be collected which contains the opposite tasting fraction of the hydrolysate. Preferably the siloxane is selected from the group comprising octa-siloxane and octadecyl-siloxane. Preferably the hydrolysate has a molecular weight of less than 10,000, and is derived from the group of hydrolysates comprising casein, whey and soy. Additionally, the bed preferably is of a depth of between 2 to 4 times the bed diameter. A more hypoallergenic protein hydrolysate product produced in accordance with the method of the invention is also disclosed.

Debittered protein product having improved antigenicity and method for

This invention describes a product obtained from the isolation and concentration of specific immunoglobulins (antibodies) derived from the mammary secretions of cows immunized with Helicobacter pylori. The product is useful in preparing formulations for the treatment and/or prevention of gastric diseases.

Method and product for the treatment of gastric disease

Disclosed are ultrafiltration processes for the enrichment and concentration of selected proteins from protein conaining fluids. Illustratively, IgG is concentrated from whey by means of multiple ultrafiltration 'passes', using a metallic oxide ultrafiltration membrane, which are characterized by differing pH's.

Enrichment and concentration of proteins by ultrafiltration

Growing community of inventors

Centerburg, OH, United States of America

Christopher T Cordle